A number of other analysts have also recently weighed in on FMS. Royal Bank Of Canada reissued a neutral rating and issued a price objective on shares of Fresenius Medical Care in a research report on Tuesday, August 8th. Zacks Investment Research cut Fresenius Medical Care from a strong-buy rating to a hold rating in a research report on Wednesday, August 16th. Finally, BidaskClub cut Fresenius Medical Care from a buy rating to a hold rating in a research report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $48.50.
Shares of Fresenius Medical Care (NYSE FMS) traded down $0.14 during midday trading on Monday, reaching $49.76. The company’s stock had a trading volume of 225,948 shares, compared to its average volume of 302,473. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.22 and a quick ratio of 0.98. The company has a market cap of $30,530.00, a PE ratio of 22.37, a PEG ratio of 2.25 and a beta of 0.45. Fresenius Medical Care has a 1-year low of $38.42 and a 1-year high of $50.22.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://baseballnewssource.com/markets/fresenius-medical-care-corporation-fms-receives-buy-rating-from-dz-bank-ag/1781083.html.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with our FREE daily email newsletter.